Understanding Medications in Multiple Sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study helps people with MS understand their medications better by having a healthcare person visit your home to review what you're taking and how you're using it. The goal is to make sure you're getting the most benefit from your medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have a confirmed diagnosis of multiple sclerosis
- Live in your own home (not in a care facility)
- Be taking at least one prescribed medication
- Speak English
- Be willing to have a healthcare visitor come to your home to talk about your medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with multiple sclerosis to learn more about the disease and how it affects overall health. Researchers will collect information about your symptoms, treatments, and health outcomes over time to better understand MS and improve care.
This trial is looking at how people with multiple sclerosis experience clinical study enrollment and participation. It may help improve how future MS trials work and are explained, especially for different types of participants.
This study looks at how switching or failing multiple sclerosis (MS) treatments affects your feelings and daily life. It may help doctors better support people with relapsing-remitting MS.
This study looks at how multiple sclerosis affects thinking, energy, mood, and behavior. It uses simple tests and questionnaires to understand your unique profile, which may help tailor future care.
This study looks at whether the amount of MS treatment-related “burden” in the mouth and body affects how well people stick to their disease-modifying therapy. It may help doctors understand which patients are more likely to have trouble following treatment after switching or starting certain MS medicines.
This trial aims to develop a new care model for people with multiple sclerosis (MS). It includes patients, caregivers, and healthcare professionals to ensure the best care possible.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.